When most people think of parasites affecting their pets, they imagine heartworms in dogs or roundworms in cats. However, ...

Merck Veterinary Manual, Care Credit, ASPCA Pet Health Insurance, Pet Food Processing, and Pew Research Center.

A dog's double coat plays a key role in keeping them safe and healthy. Shaving such canines can result in several uncomfortable consequences.

The number of calories a cat needs varies based on age and activity level. The Merck Veterinary Manual says kittens should be given multiple meals daily and allowed to eat as much as they want ...

Best Friends, Hill’s Pet Nutrition, American Veterinary Medical Association, American Pet Products Association, Experian, Merck Veterinary Manual, Care Credit, ASPCA Pet Health Insurance, Pet Food ...

The Merck Veterinary Manual: This a go-to guide on many of the diseases and ailments you may run into as a vet, including the etiology, clinical findings, diagnoses, and the treatments for them. In ...

Early on during the epidemic, veterinary and human vaccine candidates ... “Those are the US Merck or MSD and Boehringer Ingelheim. All the other companies, whether it was Eli Lilly, or Pfizer ...

Shares of global pharmaceutical company Merck (NYSE:MRK) fell 11% in the morning session after the company reported mixed fourth-quarter earnings. Its full-year revenue and EPS guidance missed by ...

Merck stock (NYSE: MRK) lost about 10% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year. Despite strong performances from other pharmaceutical giants like Eli ...

For the recently completed fourth quarter, Merck booked an adjusted profit of $1.72 per share on $15.6 billion in revenue. Sales of top-selling cancer treatment Keytruda climbed 19% to $7.84 billion.

Merck reported Q4 sales of $15.62 billion, up 7% YoY, exceeding the $15.49 billion estimate. Goldman Sachs raises Merck's price target to $135, citing growth potential. Get real-time earnings ...

Merck faces headwinds like declining sales of the HPV vaccine, Gardasil, and diabetes drug, Januvia. Merck faces broader industry pressure as vaccine skeptic Robert F. Kennedy Jr. possibly next ...